Sign Up to like & get
recommendations!
0
Published in 2022 at "Cutaneous and Ocular Toxicology"
DOI: 10.1080/15569527.2022.2124413
Abstract: Abstract Purpose Bevacizumab is a recombinant humanized monoclonal antibody that specifically binds to vascular endothelial growth factor (VEGF). Cutaneous side effects of bevacizumab are seen with substantial frequency and may require the interruption of the…
read more here.
Keywords:
group;
carvacrol bevacizumab;
bevacizumab;
effect carvacrol ... See more keywords